Matthias Gerhard Wacker - National University of Singapore

基本信息

浏览量：9

职业迁徙

个人简介

Our lab specializes in the development of in vitro performance assays for injectables and perorally applied dosage forms. We utilize biopredictive in vitro release assays and physiologically-based biopharmaceutics modelling to explain and predict the in vivo behavior of long-acting depot formulations, liposomal delivery systems and peroral dispersions. Read more on our website www.nanomedicines.de

研究兴趣

论文共 114 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Second Phase of Tumor Invasion Driven by Immune Cells: A Study on Doxorubicin-Loaded PLG Nanoparticles

Julia Malinovskaya,Tatyana Kovshova,Pavel Melnikov, Zhuoxuan Li, Namrata Dhakal,Julian Knoll,Marat Valikhov,Yulia Ermolenko,Anastasia Chernysheva, Olga Gurina,Vladimir Chekhonin,Matthias G. Wacker,Svetlana Gelperina

JOURNAL OF CONTROLLED RELEASE（2025）

引用0浏览0WOS引用

Chloroquine Induces Eryptosis in P. Falciparum-Infected Red Blood Cells and the Release of Extracellular Vesicles with a Unique Protein Profile

Claudia Carrera-Bravo, Tianchi Zhou, Trang Chu, Jing Wen Hang,Harshvardhan Modh, Chenyuan Huang, Sitong Zhang, Haining Hao, María José Cabada-García, Benoit Malleret,Matthias G Wacker,Jiong-Wei Wang,Laurent Rénia,Kevin S W Tan

Frontiers in cellular and infection microbiology (2025): 1553123-1553123

引用0浏览0WOS引用

BioJect: an in Vitro Platform to Explore Release Dynamics of Peptides in Subcutaneous Drug Delivery